老年人康复治疗：益处、预期效果及其对健康老龄化的支持

Overview

Microscopic polyangiitis (MPA) is a rare type of autoimmune vasculitis, a condition where your immune system mistakenly attacks small blood vessels in your body. This inflammation narrows or blocks vessels, reducing blood flow to organs, most commonly the kidneys and lungs. MPA is part of a group of conditions called ANCA-associated vasculitides, named for the abnormal anti-neutrophil cytoplasmic antibodies (ANCA) often found in blood tests. While MPA is a serious, chronic condition, early diagnosis and consistent treatment can help most people manage symptoms and prevent permanent organ damage.

Signs & Symptoms

MPA symptoms vary depending on which organs are affected, and they often develop gradually over weeks or months. Some people experience mild, nonspecific symptoms early on, which can delay diagnosis.

• General symptoms: Fatigue, fever, unintentional weight loss, muscle and joint pain, and night sweats
• Kidney symptoms (most common): Blood in the urine (making it look pink or cola-colored), foamy urine from excess protein, swelling in the legs or around the eyes, and high blood pressure
• Lung symptoms: Shortness of breath, persistent cough, and in rare cases, coughing up blood
• Other possible symptoms: Skin rashes, purple spots (purpura), nerve damage causing numbness or tingling in the hands or feet, and sinus inflammation

Causes & Risk Factors

The exact cause of MPA is not fully understood, but it is an autoimmune condition, meaning your immune system attacks healthy tissue by mistake. Most people with MPA have ANCA antibodies in their blood, which activate immune cells to inflame blood vessels. Risk factors for developing MPA include: a personal or family history of other autoimmune conditions, exposure to certain medications (like hydralazine or propylthiouracil) or environmental toxins, and being between the ages of 40 and 60 (though MPA can occur at any age). MPA is not contagious, and you cannot catch it from another person.

Diagnosis

Diagnosing MPA can be challenging because early symptoms are often vague and overlap with other conditions. Your healthcare team will use a combination of tests to confirm a diagnosis:

Treatment & Management

There is no cure for MPA, but treatment can put the condition into remission (no active symptoms) and prevent organ damage. Treatment typically has two phases: induction (to stop active inflammation quickly) and maintenance (to keep the condition in remission long-term). Common treatments include:

• Corticosteroids (like prednisone) to reduce inflammation quickly, usually at a high dose at first, then tapered over time
• Immunosuppressive medications (like rituximab, cyclophosphamide, or methotrexate) to slow or stop the immune system from attacking blood vessels
• Plasmapheresis (a procedure that filters ANCA antibodies out of the blood) for severe cases with kidney or lung damage
• Additional medications to manage related symptoms, like blood pressure drugs for kidney-related hypertension

Living With It

Long-term management of MPA involves regular follow-up with your healthcare team, including a rheumatologist (who specializes in autoimmune conditions) and a nephrologist (who specializes in kidney care). You will need regular blood and urine tests to monitor for organ damage and medication side effects. Many people with MPA are able to live full, active lives with consistent care and lifestyle adjustments.